X

Vous n'êtes pas connecté

Maroc Maroc - ONCOLOGYNEWS.COM.AU - A La Une - Hier 15:33

Rare side effect of cancer immunotherapy

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes. In recent years, CAR-T cell therapies have become an essential part of the treatment of patients whose lymphoma or multiple myeloma has relapsed. This involves genetically modifying the patient’s T lymphocytes (T cells) to [...]

Articles similaires

Development of lymphoma following CAR-T cell therapy

news.medical.net - 22/Feb 15:04

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.

Are Allogeneic CAR-Ts the Future of LBCL Cancer Treatment? - Making Safe, Durable & Effective Universal Cell Therapies a Reality

news.medical.net - 04/Mar 16:07

Allogene Therapeutics recently released exciting results from the Phase 1 ALPHA/ALPHA2 trials of the Allogeneic CAR T 'Cemacabtagene...

Gene modification could improve cancer treatment’s success rate

oncologynews.com.au - 23/Feb 15:56

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves...

Co-located cell types help drive aggressive brain tumours

oncologynews.com.au - 23/Feb 16:03

A type of aggressive, treatment-resistant brain tumour has a distinct population of immune cells that support its growth, according to new research...

Study identifies immune response that may stop breast cancer from spreading

oncologynews.com.au - 00:36

A new Moffitt Cancer Centre study has identified a specific immune response that may prevent the spread of breast cancer cells within the body....

NICE recommends lisocabtagene maraleucel cell therapy for eligible patients with relapsed or refractory large B-cell lymphomas

oncologynews.com.au - 18:11

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance...

Sorry! Image not available at this time

Simple blood test ‘could predict risk of major diseases decades later’

news.stv.tv - 26/Feb 08:42

The highest risk of dementia was found in people whose immune system aged faster than usual – not in people whose brains aged more rapidly.

Human Lungs: A Reservoir for Blood Stem Cells

medindia.net - 28/Feb 13:50

Discover groundbreaking research showing that lungs, alongside bone marrow, play a crucial role in blood cell production, offering new insights for...

FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma

oncologynews.com.au - 23/Feb 00:13

On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin in combination with lenalidomide and a rituximab product for adult...

Researchers reveal molecular mechanisms in cancer cells

oncologynews.com.au - 03/Mar 15:22

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup. Researchers at RPTU University...

Les derniers communiqués

  • Aucun élément